The tyrS genes from Escherichia coli and BaciUus stearothermophilus were toxic to E. coli when they were carried by plasmids with very high copy numbers (pEMBL8 and pEMBL9). We quantified this effect by comparing the efficiencies of plating of E. coli derivatives harboring recombinant plasmids in various experimental conditions. The toxicity was apparent at both 30 and 37C. It increased with the growth temperature, the strength of the tyrS promoter, and the copy number of the plasmidic vector. Two-to threefold enhancement of tyrS expression raised the toxicity 300-fold. Point mutations in tyrS that prevent interaction between its product, tyrosyl-tRNA synthetase, and tRNATIr but do not alter the rate of formation of tyrosyl-adenylate abolished the toxicity. Thus, the toxic effect was due to high cellular levels of synthetase activity. At 30°C, the cellular concentration of tyrosyl-tRNA synthetase reached 55% of that of soluble proteins and led to decreased ,B-galactosidase stability. We discuss possible causes of this toxic effect and describe its applications to the study of the recognition and interaction between the synthetase and tRNATYr.
Some DNA fragments are difficult to clone into multicopy plasmids of Escherichia coli because an encoded product or function or merely their nucleotide sequence interferes with replication of the vector or with cellular metabolism. For example, basic proteins can inhibit transcription or translation by binding to the nucleic acids (8, 15) , exported proteins can jam the cellular export machinery (13, 19) , and strong promoters (17) or long palindromes (9) can prevent plasmid replication. Although such cloning problems are common, they are rarely analyzed in detail. We performed such an analysis for the gene of an aminoacyl-tRNA synthetase.
The tyrS genes of E. coli (tyrSEC) and Bacillus stearothermophilus (tyrSBS) code for tyrosyl-tRNA synthetase (TyrTS), an enzyme which catalyzes the aminoacylation of tRNATYr with tyrosine in a two-step reaction. The tyrosine is first activated with ATP to form tyrosyl-adenylate (Tyr-AMP) and PP, and then Tyr-AMP is attacked by the 3'-terminal ribose of the tRNA to form tyrosyl-tRNATYr and AMP.
The tyrSEc and tyrS., genes were originally cloned as Sau3aI fragments into the BamHI site of plasmid pBR322 (1) . tyrSBS was subsequently subcloned into an M13-derived phage after trimming of unnecessary sequences. It is strongly expressed from recombinant bacteriophage M13-BY(M24) under the control of its own promoter. Mutations in the untranslated 5' region of tyrSBS were constructed in vitro. One such mutation, tyrSBS(M24.89), results in two-to threefold enhancement of tyrS expression (21) . Numerous mutations have been constructed in this overexpressed gene (4, 7, 11) .
In this report, we show that when subcloned into a very high-copy-number plasmid, the tyrS gene was toxic to the host cell. We report a genetic analysis of this phenomenon and describe its potential uses for the study of the interaction between TyrTS and tRNATYr.
MATERIALS AND METHODS
Media and strains. The media used, LB, M63, and MacConkey, have already been described (14) . M63 buffer is M63 medium without a carbon source. Ampicillin was added at 100 ,ug/ml, and kanamycin was added at 50 pLg/ml. The plasmids and bacteriophages used are listed in Table 1 . Strain TG2 of E. coli K-12 [A(lac-pro) supE thi hsdD5 recA56 srl::TnJO(F' traD36 proA+B+ lacIq lacZAM15)] was a gift from T. Gibson. HB2201 is a female derivative of TG2; HB2202 is identical to TG2 except that it carries a lac+ episome, F' proA+B+ lacIql lacZ+ Y+ (a gift from J. Miller).
Plasmid constructions. Plasmids pEMBL8+ and pEMBL9+ have their cloning sites in opposite orientations (6) . Plasmids pEMBL8+K and pEMBL9+K were constructed by inserting the kanamycin resistance cartridge of plasmid pUC-4K into the PstI sites of plasmids pEMBL8+ and pEMBL9+, respectively. A double cut of pEMBL9+K with HindIlI and EcoRI or of pEMBL8+K with Sall and HindIII releases a fragment which corresponds to the cartridge and can easily be visualized by electrophoresis in an agarose gel. Insertion of a fragment in place of the cartridge can be monitored by loss of kanamycin resistance (lOa).
In our first subcloning experiments, we purified all of the DNA fragments before ligation, as previously described (3) P-mercaptoethanol, 0.1 mM phenylmethylsulfonyl fluoride), and samples were stored frozen at -20°C. After thawing, the cell suspensions were sonicated in a cup horn and the debris was removed by centrifugation. Active-site titration of TyrTS in the soluble extracts was performed as already described (23) . Sodium PP, was added to the reaction mixture to displace unlabeled Tyr-AMP from TyrTS and then hydrolyzed with pyrophosphatase to initiate formation of 14C-labeled Tyr-AMP. The concentrations of protein in the extracts were measured with the Bio-Rad reagent with bovine serum albumin as the standard.
Inactivation of 0-galactosidase. Several isolated colonies without papillae were suspended from a fresh master plate containing 1 mM isopropyl-fi-D-thiogalactopyranoside (IPTG) into 200 ,ul of M63 buffer, and samples were stored frozen at -20°C. The soluble extract was prepared as described above and then diluted about 20 times in M63 buffer. Samples (100 ,ul) were incubated for various times at either 56.0 or 57.0°C (t0.05°C). One sample was removed every 5 min for 30 min and immediately cooled on ice. After centrifugation of the protein precipitate, the supernatant was assayed for 3-galactosidase activity (14) . RESULTS
Cloning of tyrSg. and tyrSEr into pEMBL. In phage M13-BY(M24), the tyrS gene and its promoter belong to a HindIII-EcoRI fragment. We inserted this fragment betWeen the HindIII and EcoRI cloning sites of plasmids pEMBL9+K and pBR322. Similarly, we subcloned several mutant alleles of tyrSBs from M13-BY(M24) derivatives into pEMBL9+K.
We also inserted the SalI-HindIII fragment of pBR322-EY that contains tyrSEc and its promoter between the SalI and HindIII cloning sites of pEMBL8+K ( Fig. 1 ; Table 1 ).
In preliminary experiments, we grew the transformed bacteria at 37°C. However, when we tried to insert the tyrSBs (2, 22, 24) . The concentrations of TyrTS were normalized with respect to the total concentrations of protein in the soluble extracts and are expressed as percentages. I The HB2202 derivatives were streaked on minimal M63B1 medium containing glucose as the carbon source, proline, and ampicillin. After 48 h of growth at 30°C, the diameters of the colonies were recorded. ND, Not determined; 0.00, no colony.
control of promoters M24 and M24.89 (Table 3 , lines 2, 3, 7, and 8). Changing the plasmid vector from pBR322 to pEMBL had no effect on production of TyrTSBS but resulted in a 1.5-fold increase in production of TyrTSEc (Table 3, lines 3, 6, 11, and 12).
Thus, although the titration and plating experiments were done in different conditions, they showed a clear correlation between the cellular concentration of active TyrTS during growth at 30°C and its toxicity at 37°C.
Toxicity at 30°C. The results obtained with cultures in LB broth had suggested to us that plasmid pEMBL9-BY (M24.89) inhibited the growth of its bacterial host at 30°C (see above). To further substantiate this observation, we streaked strain HB2202 and its derivatives on minimal glucose and on lactose or galactose indicator plates containing ampicillin and incubated them at 30°C for 48 h. On minimal medium, the diameters of the colonies (Table 3) correlated with the cellular concentrations of active TyrTS at 30°C and with its toxicity at 37°C (Tables 2 and 3 ). In particular, bacteria containing pEMBL9-BY(M24.89) did not grow at all, whereas those containing pEMBL9+ gave large colonies. Thus, overexpression of the tyrS gene prevented cell growth on minimal medium at 30°C. On MacConkey plates, all of the HB2202 derivatives were strongly Lac' and Gal', except HB2202[pEMBL9-BY(M24.89)], which was only weakly Lac' and Gal' (pink). This suggested to us that the activity or stability of ,-galactosidase and essential proteins might be altered in a strain overexpressing tyrS.
Thermal stability of I8-galactosidase. To determine whether overexpression of tyrS alters the structural properties of cellular proteins, we suspended colonies of HB2202 derivatives in buffer, prepared their soluble extracts, and determined the kinetics of inactivation of ,-galactosidase, taken VOL. 172, 1990 on August 14, 2017 by guest http://jb.asm.org/ Downloaded from as a test protein, at 56 and 570C (Table 4) . When ,Bgalactosidase was synthesized by HB2202[pEMBL9-BY (M24.89)], its inactivation half-time was about half of the normal value, i.e., the value obtained with an extract of the control strain, HB2202(pEMBL9+). This decrease in stability was abolished by point mutation K410N. These results showed that it was overproduction of active TyrTS during growth at 30°C that decreased the stability of P-galactosidase.
DISCUSSION
We found that overproduction of active TyrTS was toxic to E. coli. This toxicity was apparent at both 30 and 37°C, but its effect was stronger at 37°C. Overproduction of TyrTS decreased the stability of ,-galactosidase.
The results showed a clear correlation between the toxicity of the plasmids carrying the tyrS gene and the cellular concentration of active TyrTS, although it was not possible to measure them in identical conditions. Indeed, the toxicity in the plating experiments at 37°C, the inhibition of growth in broth or on minimal medium at 300C, and the concentration of TyrTS in cells growing at 30°C increased together with the strength of the tyrS promoter and, to a lesser extent, with the copy number of the plasmidic vector.
In cells growing at 30°C, the concentration of active TyrTSB, increased threefold when we replaced the wild-type promoter tyrSp(M24) with mutant promoter tyrSp(M24.89), which is two to three times stronger (21) , and it amounted to 55% of the soluble proteins. Replacement of the wild-type promoter by the mutant promoter resulted in strong inhibition of growth at 30°C and in a 300-fold increase of toxicity at 37°C. Thus, toxicity occurred at high concentrations of TyrTS and at these cellular levels, a weak increase in TyrTS expression resulted in a strong enhancement of toxicity. The half-time of ,-galactosidase inactivation at 56 and 57°C was reduced when the enzyme was synthesized by a strain that overproduced TyrTS compared with when it was synthesized by strains that did not overproduce it or overproduced a partially inactive synthetase, TyrTS(K410N). The effect was small (about twofold) but reproducible (Table  4) . On the basis of the results, we can conclude that it was overexpression of TyrTS activity (more precisely, its interaction with tRNAs but not formation of Tyr-AMP) that decreased the stability of 3-galactosidase. Swanson et al. (18) have shown that if E. coli glutaminyl-tRNA synthetase is overproduced in vivo, it incorrectly acylates tRNATYr with Gln. A similar mechanism could explain the decreased stability of ,-galactosidase in our experiments: high cellular levels of TyrTS could result in mischarging of noncognate tRNAs and thus in misincorporation of tyrosine in P-galactosidase. Hall and Gallant have shown that amino acid starvation results in thermolabile ,B-galactosidase (10) . High levels of TyrTS could drain the tRNA pool and starve the cell for Tyr-tRNATYr, resulting in mistranslated proteins. A low level of mistranslation in ,-lactamase could explain the fourfold difference between the efficiencies of plating of strain HB2202[pEMBL9-BY(M24.89)] at 37°C on medium with or without ampicillin ( Table 2 , line 2).
How can we explain the effect of temperature on TyrTS toxicity? The average coefficient of temperature for enzymatic reactions is Q1o = 2 (12); therefore, decreasing the temperature from 37 to 30°C should decrease the activity of TyrTS about 1.4 times. Such a decrease could have an important effect on toxicity, since our results showed that a 2-to 3-fold decrease in the strength of the tyrS promoter resulted in a 325-fold increase in cell viability. We found that overproduction of TyrTS decreased the stability of ,3-galactosidase. If this effect is general, essential proteins might be active at 30°C and become partially inactive at 37°C, which would affect cell growth or viability.
The correlations between our different experiments were not absolute. We see two possible causes. The plasmid copy numbers are strongly dependent on the physiological state of the host cells and on their growth rate (17) . The toxicity of wild-type TyrTS could contribute to its own overproduction relative to the other cellular proteins by slowing down or precociously stopping bacterial growth.
The toxicity of TyrTS should be useful for the study of the recognition of tRNATYr by TyrTS. Indeed, an increase of its production by a factor of only 2 to 3 resulted in a toxic effect multiplied 300-fold. Thus, by cloning mutant tyrS genes into pEMBL9+ and by testing the toxicity of the recombinant plasmids, we shall be able to strongly amplify little differences in the activity or specificity of charging of their product, which, by in vitro kinetic experiments, would be near the limit of detection. By mutagenizing the tyrS gene under the control of promoter Ptac, we shall be able to screen for conditionally lethal mutants with increased TyrTS activity or decreased specificity in the recognition of tRNATYr. By selecting bacteria that contain pEMBL9-BY(M24.89) and are able to grow on minimal medium, we could isolate mutants with decreased activity or increased specificity.
